Testing effectiveness (Phase 2)Study completedNCT07335952
What this trial is testing
Proximod, a Selective Sphingosine-1-phosphate Receptor 1 Modulator in Patients With Moderate-to-severe Active Rheumatoid Arthritis: a Double-blind, Randomised, Placebo-controlled, Phase 2 Trial.
Who this might be right for
Rheumatoid Arthritis
Peking University People's Hospital 179